These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


535 related items for PubMed ID: 17224655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade.
    Valera ET, Latorre Mdo R, Mendes WL, Seber A, Lee ML, de Paula MJ, Loggetto SR, Velloso E, Niero-Melo L, Lopes LF, Brazilian Cooperative Group on Pediatric Myelodysplastic Syndromes.
    Leuk Res; 2004 Sep; 28(9):933-9. PubMed ID: 15234570
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Allogeneic transplantation of haematopoietic progenitors for myelodysplastic syndromes and myeloproliferative disorders.
    Locatelli F, Giorgiani G, Comoli P.
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S17-20. PubMed ID: 9630318
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
    Niemeyer CM, Kratz CP.
    Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CMML: a biologically distinct myeloproliferative disease.
    Cortes J.
    Curr Hematol Rep; 2003 May; 2(3):202-8. PubMed ID: 12901341
    [Abstract] [Full Text] [Related]

  • 17. Focus on myeloproliferative diseases and myelodysplastic syndromes.
    Van Etten RA, Shannon KM.
    Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
    [No Abstract] [Full Text] [Related]

  • 18. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
    Tiu RV, Sekeres MA.
    Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.